About   Help   FAQ
Suprmam1C57BL/6J
QTL Variant Detail
Summary
QTL variant: Suprmam1C57BL/6J
Name: suppressor of mammary tumors 1; C57BL/6J
MGI ID: MGI:3715517
QTL: Suprmam1  Location: unknown  Genetic Position: Chr7, Syntenic
Variant
origin
Strain of Specimen:  C57BL/6J
Variant
description
Allele Type:    QTL
Notes

Mapping and Phenotype information for this QTL, its variants and associated markers

J:122161

Linkage analysis was performed on 224 female (C57BL/6J x BALB/cMed-Trp53tm1Tyj)F1 x BALB/cMed-Trp53tm1Tyj backcross animals to identify genetic modifiers of mammary tumor susceptibility. Female animals were monitored weekly for tumor development and morbidity for 18 months. Genome scan was performed by genotyping 150 single nucleotide polymorphisms (SNPs) in pooled DNA from tumor-bearing (n=85) and non-tumor-bearing (n=91) mice.

A locus on mouse Chromosome 7 showed significant linkage to mammary tumor development in Trp53tm1Tyj heterozygous animals with LOD=3.5 near SNP marker M64879_201_1. This QTL spans 107.9 Mb - 120.5 Mb and is named Suprmam1 (suppressor of mammary tumors 1). There are potentially 2 QTLs within this interval. Homozygosity for BALB/cMed-derived alleles at Suprmam1 in conjunction with one Trp53tm1Tyj allele confers increased incidence of mammary tumors, decreased tumor latency by 10 weeks (61.1 weeks vs 70.7 weeks), and decreased mammary tumor-free survival.

Microarray analysis was performed on mammary tissue RNA from C57BL/6J-Trp53tm1Tyj and BALB/cMed-Trp53tm1Tyj animals to identify candidate genes for Suprmam1. Hbb-b2 (50 cM) and Spon1 expression is increased in BALB/cMed-Trp53tm1Tyj compared to C57BL/6J-Trp53tm1Tyj while Trim12, Thumpd1 (59 cM), and Dmbt1 expression is decreased in BALB/cMed-Trp53tm1Tyj. Dbmt1 is of particular interest because it has been previously described as a putative tumor suppressor gene. Dmbt1 expression is expressed >5-fold specifically in the mammary glands of C57BL/6J-Trp53 compared to BALB/cMed-Trp53. Decreased DMBT1 expression is also associated with breast cancer susceptibility in human females.

References
Original:  J:122161 Blackburn AC, et al., Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol. 2007 Jun;170(6):2030-41
All:  1 reference(s)

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory